SEP 2014 ARTICLE LIST >>
PharmaTutor (September- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 9)
Received On: 13/04/2014; Accepted On: 30/06/2014; Published On: 01/09/2014
AUTHORS: Mayuri Lawar1, Varsha Shende1*, Suvarna Ingle2, Monali Sanghvi1, Naeem Hamdulay1
1Department of Pharmacology, Sinhgad College of Pharmacy, Post-Graduate Research Department, Off Sinhgad road, Vadgaon (Bk), Pune, Maharashtra, India.
2Department of Pharmacology, Indira College of Pharmacy, New Pune Mumbai Highway, Tathwade, Pune, Maharashtra, India.
*shende.varsha@gmail.com
ABSTRACT:
Depression and related mood disorders are among the world’s greatest public health problems. Mimosa pudica L. (MP), a creeping perennial herb exhibits analgesic, anxiolytic, diuretic, antiasthmatic, hepatoprotective activities. Although, previous study reveal antidepressant like effects of aqueous extract of MP at behavioral levels, but antidepressant like effects of hydroalcoholic extract of Mimosa pudica L. (HEMP) and its combinational effect with standard antidepressant drugs at behavioral and biochemical level is not scientifically evaluated. Hence, the present investigation evaluates the antidepressant activity of HEMP and its interaction with fluoxetine and imipramine in reserpine-induced behavioural despair in rats and the potential mechanism involved in HEMP action. HEMP at doses 50, 100 and 200 mg/kg p.o., fluoxetine at 5 & 20mg/kg p.o., imipramine at 5 & 15 mg/kg p.o. and reserpine 6 mg/kg i.p. were administered to different groups of rat (n=6). After reserpine treatment, rats were subjected to forced swimming test followed by assessment of locomotor activity. Rats were sacrificed after behavioural study for estimation of serotonin, monoamine oxidase (MAO) levels in rat brain. Results demonstrate that combination of subeffective doses of HEMP, fluoxetine and imipramine reduced the duration of immobility in forced swimming test, increased serotonin and decreased MAO-A and MAO-B enzyme levels in reserpine treated rats. These findings suggest that combination of HEMP with standard drugs in subeffective doses can exert potential antidepressant like effect through modulation of brain serotonergic system and MAO inhibition.
How to cite this article: M Lawar, V Shende, S Ingle, M Sanghvi, N Hamdulay; Effect of Hydroalcoholic extract of Mimosa Pudica Linn. with Imipramine and Fluoxetine on Reserpine-induced Behavioural Despair in Rats; PharmaTutor; 2014; 2(9); 123-134
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Seo MK, Song JC, Lee SJ, Koo KA, Park YK, Lee JG, Park SW and Kime YH. Antidepressant-like effects of Bupleuri Radix extract. European Journal of Integrative Medicine, 2012;4(4):392-399.
2. Loya AM, Gonzalez-Stuart A and Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplements use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study. Drugs Aging, 2009; 26(5): 423-436.
3. Dahanukar SA , Kulkarni RA and Rege NN. Pharmacology of medicinal plants and natural products. Indian Journal of Pharmacology, 2000; 32: S81-S118.
4. Detke MJ, Rickels M and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Pshycopharmacology, 1995;121: 66-72.
5. Annonymous. Common sensitive plant Mimosa pudica, Fact sheet, Land Protection (Invasive Plants and Animals) department of primary industries and fisheries, queensland. Available from: dpi.qld.gov.au/4790_7242.html [2007; cited 8 November 2011.]
6. Pande M and Pathak A. Preliminary pharmacognostic evaluations and phytochemical Studies on roots of Mimosa pudica (lajvanti). Int J Pharm Sci Rev Res., 2010;1(1): 50-52.
7. Sharma PC, Yelne MB and Dennis TT. Database on medicinal plants Govt. of India. 2001; 369-379.
8. Annonymous. The World Health Report. Mental health: new understanding new hope.WHO, Geneva, 2001.
9. Vaidyaratanm PS. Indian Medicinal Plants database Kottakkal. Arya Vidyashala: Orient Longman, 2001; 2.
10. Kokane DD, More RY, Kale MB, Nehete MN, Mehendale PC and Gadgoli CH. Evaluation of wound healing activity of root of Mimosa pudica. Journal of Ethnopharmacology, 2009; 124(2): 311-315.
11. Ayissi MR, Gartside S, Bum E, Njikam N, Okello E and McQuade R. Effect of Mimosa pudica (Linn.) extract on anxiety behaviour and GABAergic regulation of 5-HT neuronal activity in the mouse. Journal of Psychopharmacology, 2012; 26(4): 575-583
12. Molina M, Contreras CM and Alcantara P. Mimosa pudica may possess antidepressant actions in the rat. Phytomedicine, 1999; 6(5): 319-323.
13. Kumar BK, Ramesh C, Eienstien J, Girish K and Saleem BS. Evaluation of antiulcer activity of mimosa pudica Ethanolic extract in rats. International Journal of Pharm Sciences, 2011; 2(4);1117-1124.
14. Ganguly M, Devi N, Mahanta R and Borthakur MK. Effect of Mimosa pudica root extract on vaginal estrous and serum hormones for screening of antifertility activity in albino mice. Contraception, 2007; 76(6): 482-485.
15. Muthukumaran P, Padmapriya P, Salomi S, Umamaheshwari R, Kalaiarasan P, and Malarvizhi C. In vitro antimicrobial activity of leaf powder. Asian Journal of Pharmaceutical Research, 2011; 1(4):108-110.
16. Amalraj T and Ignacimuthu S. Hyperglycemic effect of leaves of Mimosa pudica Linn. Fitoterapia, 2002; 73(4): 351-352.
17. Ngo BE, Dawack D L, Schmutz M, Rakotonirina A, Rakotonirina S V, Portet C, Jeker A, Olpe HR and Herrling P. Anticonvulsant activity of Mimosa pudica Decoction. Fitoterapia, 2004; 75(3-4): 309-314.
18. Rajendran R and Krishnakumar E. Hypolipidemic Activity of Chloroform Extract of Mimosa pudica Leaves. Avicenna Journal of Medical Biotechnology, 2010; 2(4): 215-221.
19. Rangari V. “Pharmacognosy and Phytochemistry”, Career publications, Nashik, 2002; 1(1).
20. Khandelwal K. “Practical Pharmacognosy”, Nirali Prakashan, Pune, 2008; 19.
21. McDonald S, Prenzler PD, Autolovich M and Robards K. Phenolic content and antioxidant activity of olive extracts. Food Chemistry, 2001;73(1): 73-84.
22. Bolandghamat S, Moghimi A and Iranshahi M. Effects of ethanolic extract of pine needles (Pinus eldarica Medw.) on reserpine-induced depression-like behavior in male Wistar rats. Pharmacognosy Magazine, 2011; 7(27):248-253.
23. Clark CT, Weissbach H and Udenfriend SJ. The Estimation of 5-hydroxytrptamine (Serotonin) in biological tissues. The Journal of Biological Chemistry, 1954; 210: 337-344.
24. PanY, Kong L, Xia X, Zhang W, Xia Z, Jiang F. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacology Biochemistry and Behavior, 2005; 82(4):686-694.
25. Porsolt RD, Anton G, Blavet N and Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. European Journal of Pharmacology, 1978; 47: 379-391.
26. Dhir A, Malik S, Kessar SV, Singh KN, Kulkarni SK. Evaluation of antidepressant activity of 1-(7-methoxy- 2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)- cyclohexanol, a β-substituted phenylethylamine in mice. European Neuropsychopharmacology, 2011; 21(9): 704-714.
27. Porsolt RD, Bertin A and Jalfre M. Behavioural despair in rats and mice: Strain differences and the effects of imipramine. European Journal of Pharmacology, 1978; 51(3): 291-294.
28. Yi LT, Li CF, Zhan X, Cui CC, Xiao F, Zhou LP, Xie Y. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2010; 34(7): 1223–1228.
29. Kandel ER. “Principles of neural science”, McGraw-Hill Companies, New York, 2000;1216–1217.
30. Myron A and Hoffer MD. Effects of reserpine and amphetamine on the development of hyperactivity in maternally deprived rat pups. Psychosomatic Medicine, 1980; 42(5), 513–520.
31. O’Gara BA, Chae H and Latham LB. Modification of leech behavior patterns by reserpine-induced amine depletion. The Journal of Neuroscience, 1991; 11(1), 96-110.
32. Messiha FS. Effect of Amantadine on Chlorpromazine and Reserpine-Induced Behavioral Depression in the Mouse. Neuroscience & Biobehavioral Reviews, 1988; 12(3-4): 219-222.
33. Naughton M, Mulrooney JB and Leonard BE. A review of the role of serotonin receptors in psychiatric disorders. Human Psychopharmacology, 2000; 15(6): 397–415.
34. Ramakrishna A, Giridhar P and Ravishankar GA . Indoleamines and calcium channel influence on morphogenesis in in vitro cultures of Mimosa pudica L. Plant Signaling & Behavior, 2009; 4(12): 1136-1141.
35. Schurr A and Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochemical Pharmacology, 1976; 25(10): 1201-1203.
36. Billett EE. Monoamine oxidase (MAO) in human peripheral tissues. Neurotoxicology, 2004; 25(1-2): 139-148.
.png)
